ACT EU workshop on multiplicity in confirmatory clinical trials: From two-arm to platform trials

Workshop on the role of multiplicity in regulatory decision-making for two-arm and platform trial designs

• Datum:
  Freitag, 27 November 2026 , 09:00 - 15:00 Amsterdam time (CET)
• Ort:
  Online
  European Medicines Agency, Amsterdam, the Netherlands
  Live broadcast

Event summary

This workshop aims to address the role of multiplicity in regulatory decision-making for two-arm and platform trial designs.

The event features expert talks, use cases and moderated discussions on multiplicity issues in various settings. 

Insights from the event support the finalisation of:

• EMA guideline on multiplicity
• EMA reflection paper on confirmatory platform trials

The workshop is open to all sponsor organisations, including pharmaceutical companies, contract research organisations, small and medium-sized enterprises (SMEs) and academic organisations.

Note that certificates of attendance are not issued.

Documents

Agenda - ACT EU workshop on multiplicity in confirmatory clinical trials: From two-arm to platform trials

Draft

Live broadcast - 09:00-15:00 (CET)

The event is broadcast via this web page and no registration is required for those wishing to follow. 

Video recording is made available after the event. Processing and publication of the video recording typically take up to 60 days.

Please subscribe to the clinical trials newsletter for updates on the availability of related event video recordings.